AAAAAA

   
Results: 1-21 |
Results: 21

Authors: COITO AJ KOROM S GRASER E VOLK HD VANDEWATER L KUPIECWEGLINSKI JW
Citation: Aj. Coito et al., BLOCKADE OF VERY LATE ANTIGEN-4 INTEGRIN BINDING TO FIBRONECTIN IN ALLOGRAFT RECIPIENTS - I - TREATMENT WITH CONNECTING SEGMENT-1 PEPTIDES PREVENTS ACUTE REJECTION BY SUPPRESSING INTRAGRAFT MONONUCLEAR CELL ACCUMULATION, ENDOTHELIAL ACTIVATION, AND CYTOKINE EXPRESSION, Transplantation, 65(5), 1998, pp. 699-706

Authors: VANDIJKWOLTHUIS WNE VANDEWATER L VANDEWETERING P VANSTEENBERGEN MJ KETTENESVANDENBOSCH JJ SCHUYL WJW HENNINK WE
Citation: Wne. Vandijkwolthuis et al., SYNTHESIS AND CHARACTERIZATION OF POLY-L-LYSINE WITH CONTROLLED LOW-MOLECULAR-WEIGHT, Macromolecular chemistry and physics, 198(12), 1997, pp. 3893-3906

Authors: RIETVELD MHP TEUNISSEN W HAGEN H VANDEWATER L GROVE DM VANDERSCHAAF PA MUHLEBACH A KOOIJMAN H SMEETS WJJ VELDMAN N SPEK AL VANKOTEN G
Citation: Mhp. Rietveld et al., SYNTHESIS AND REACTIVITY OF TANTALUM ALKYLIDENE COMPLEXES CONTAINING THE C,N,N'-CHELATING ARYLDIAMINE LIGAND [C6H4(CH2N(ME)CH2CH2NME2)-2](-) (CNN) - X-RAY STRUCTURES OF [TACL2(=CH-T-BU)(CNN)], [TA((CH2)(3)-1,3) (CNN)(O-T-BU)(2)], AND [TA(CNN)(O-T-BU)(2)(H2C=CH2)], Organometallics, 16(8), 1997, pp. 1674-1684

Authors: RIETVELD MHP HAGEN H VANDEWATER L GROVE DM KOOIJMAN H VELDMAN N SPEK AL VANKOTEN G
Citation: Mhp. Rietveld et al., TANTALACYCLOBUTANE COMPLEXES CONTAINING THE POTENTIALLY C,N,N'-COORDINATING LIGAND [C6H4(CH2N(ME)CH(2)CH(2)NME(2))-2](-) (CNN) AND THEIR REACTIVITY WITH CARBON-MONOXIDE AND TERT-BUTYL ISOCYANIDE - X-RAY MOLECULAR-STRUCTURES OF [TA(CH2CH(ME)CH2-1,3)(CNN)(O-T-BU)(2)], [TA(CH2CH(PH)CH2-1,3)(CNN)(O-T-BU)(2)], [TA(C(O)((CH2)(3)-1,3))(CNN)(O-T-BU)(2)], AND [TA(C(=N-T-BU)CH2CH(PH)CH2-1,4)(CNN)(O-T-BU)(2)], Organometallics, 16(2), 1997, pp. 168-177

Authors: VANDEWATER L
Citation: L. Vandewater, SPECIALIZED IMAGING TECHNIQUES, Clinics in laboratory medicine, 17(2), 1997, pp. 299

Authors: KUPIECWEGLINSKI JW COITO AJ VANDEWATER L
Citation: Jw. Kupiecweglinski et al., EXTRACELLULAR-MATRIX PROTEINS AND THEIR INTERACTIONS WITH THE CELLULAR REPERTOIRE OF TRANSPLANT RECIPIENTS, Transplantation proceedings, 29(6), 1997, pp. 2601-2602

Authors: COITO AJ KOROM S VANDEWATER L KUPIECWEGLINSKI JW
Citation: Aj. Coito et al., DISTINCT FIBRONECTIN SPLICING VARIANTS - POTENTIAL TARGETS FOR THERAPEUTIC IMMUNOMODULATION IN ORGAN ALLOGRAFT RECIPIENTS, Transplantation proceedings, 29(1-2), 1997, pp. 1060-1061

Authors: VANDEWATER L
Citation: L. Vandewater, MECHANISMS BY WHICH FIBRIN AND FIBRONECTIN APPEAR IN HEALING WOUNDS -IMPLICATIONS FOR PEYRONIES-DISEASE, The Journal of urology, 157(1), 1997, pp. 306-310

Authors: SUBRAMANIAM M SAFFARIPOUR S VANDEWATER L FRENETTE PS MAYADAS TN HYNES RO WAGNER DD
Citation: M. Subramaniam et al., ROLE OF ENDOTHELIAL SELECTINS IN WOUND REPAIR, The American journal of pathology, 150(5), 1997, pp. 1701-1709

Authors: COITO AJ BROWN LF PETERS JH KUPIECWEGLINSKI JW VANDEWATER L
Citation: Aj. Coito et al., EXPRESSION OF FIBRONECTIN SPLICING VARIANTS IN ORGAN-TRANSPLANTATION - A DIFFERENTIAL PATTERN BETWEEN RAT CARDIAC ALLOGRAFTS AND ISOGRAFTS, The American journal of pathology, 150(5), 1997, pp. 1757-1772

Authors: DUBIN D PETERS JH BROWN LF LOGAN B KENT KC BERSE B BERVEN S CERCEK B SHARIFI BG PRATT RE DZAU VJ VANDEWATER L
Citation: D. Dubin et al., BALLOON CATHETERIZATION INDUCES ARTERIAL EXPRESSION OF EMBRYONIC FIBRONECTINS, Arteriosclerosis, thrombosis, and vascular biology, 15(11), 1995, pp. 1958-1967

Authors: REIMER CL VANDEWATER L
Citation: Cl. Reimer et L. Vandewater, DOSE-DEPENDENT INDUCTION OF ENDOTHELIAL-CELLS FROM EMBRYONIC STEM-CELLS USING VASCULAR-PERMEABILITY FACTOR (VPF VEGF)/, Molecular biology of the cell, 6, 1995, pp. 54-54

Authors: COITO AJ BROWN LF KUPIECWEGLINSKI JW VANDEWATER L
Citation: Aj. Coito et al., DIFFERENTIAL EXPRESSION OF FIBRONECTIN VARIANTS DURING CARDIAC ALLOGRAFT-REJECTION, IN RATS, Molecular biology of the cell, 6, 1995, pp. 1616-1616

Authors: DVORAK HF DETMAR M CLAFFEY KP NAGY JA VANDEWATER L SENGER DR
Citation: Hf. Dvorak et al., VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR - AN IMPORTANT MEDIATOR OF ANGIOGENESIS IN MALIGNANCY AND INFLAMMATION, International archives of allergy and immunology, 107(1-3), 1995, pp. 233-235

Authors: COITO AJ BINDER J BROWN LF DESOUSA M VANDEWATER L KUPIECWEGLINSKI JW
Citation: Aj. Coito et al., TNF-ALPHA UP-REGULATES THE EXPRESSION OF FIBRONECTIN IN ACUTELY REJECTING RAT CARDIAC ALLOGRAFTS, Transplantation proceedings, 27(1), 1995, pp. 463-465

Authors: DETMAR M YEO KT NAGY JA VANDEWATER L BROWN LF BERSE B ELICKER BM LEDBETTER S DVORAK HF
Citation: M. Detmar et al., KERATINOCYTE-DERIVED VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) IS A POTENT MITOGEN FOR DERMAL MICROVASCULAR ENDOTHELIAL-CELLS, Journal of investigative dermatology, 105(1), 1995, pp. 44-50

Authors: BROWN LF OLBRICHT SM BERSE B JACKMAN RW MATSUEDA G TOGNAZZI KA MANSEAU EJ DVORAK HF VANDEWATER L
Citation: Lf. Brown et al., OVEREXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VPF VEGF) AND ITS ENDOTHELIAL-CELL RECEPTORS IN DELAYED-HYPERSENSITIVITY SKIN REACTIONS/, The Journal of immunology, 154(6), 1995, pp. 2801-2807

Authors: COITO AJ BINDER J BROWN LF DESOUSA M VANDEWATER L KUPIECWEGLINSKI JW
Citation: Aj. Coito et al., ANTI-TNF-ALPHA TREATMENT DOWN-REGULATES THE EXPRESSION OF FIBRONECTINAND DECREASES CELLULAR INFILTRATION OF CARDIAC ALLOGRAFTS IN RATS, The Journal of immunology, 154(6), 1995, pp. 2949-2958

Authors: SENGER DR PERRUZZI CA PAPADOPOULOSSERGIOU A VANDEWATER L
Citation: Dr. Senger et al., ADHESIVE PROPERTIES OF OSTEOPONTIN - REGULATION BY A NATURALLY-OCCURRING THROMBIN-CLEAVAGE IN CLOSE PROXIMITY TO THE GRGDS CELL-BINDING DOMAIN, Molecular biology of the cell, 5(5), 1994, pp. 565-574

Authors: WHITBY DJ BROWN LF LONGAKER MT VANDEWATER L
Citation: Dj. Whitby et al., EXPRESSION OF ALTERNATIVELY SPLICED FIBRONECTIN MESSENGER-RNAS DURINGFETAL WOUND-HEALING, Journal of cellular biochemistry, 1993, pp. 118-118

Authors: SENGER DR VANDEWATER L BROWN LF NAGY JA YEO KT YEO TK BERSE B JACKMAN RW DVORAK AM DVORAK HF
Citation: Dr. Senger et al., VASCULAR-PERMEABILITY FACTOR (VPF, VEGF) IN TUMOR BIOLOGY, Cancer metastasis reviews, 12(3-4), 1993, pp. 303-324
Risultati: 1-21 |